| Date Filed | Type | Description |
| 07/23/2015 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/17/2015 |
SC 13G/A
| BAKER FELIX reports a 12.1% stake in Pharmacyclics, Inc. |
| 02/17/2015 |
SC 13G/A
| BAKER FELIX reports a 4.4% stake in BioDelivery Sciences International, Inc. |
| 01/06/2015 |
SC 13D/A
| BAKER FELIX reports a 18.1% stake in XOMA Corporation |
| 12/19/2014 |
SC 13D/A
| BAKER FELIX reports a 20.5% stake in XOMA Corporation |
| 12/16/2014 |
SC 13D/A
| BAKER FELIX reports a 21.8% stake in XOMA Corporation |
| 12/04/2014 |
SC 13D/A
| BAKER FELIX reports a 24.6% stake in XOMA Corporation |
| 05/28/2014 |
SC 13D/A
| BAKER FELIX reports a 26.8% stake in XOMA Corporation |
| 04/10/2014 |
SC 13G/A
| BAKER FELIX reports a 4.2% stake in Diadexus, Inc. |
| 02/14/2014 |
SC 13G/A
| BAKER FELIX reports a 0% stake in ViroPharma Incorporated |
| 02/14/2014 |
SC 13G/A
| BAKER FELIX reports a 4.5% stake in Threshold Pharmaceuticals, Inc. |
| 02/14/2014 |
SC 13G/A
| BAKER FELIX reports a 11.8% stake in Pharmacyclics, Inc. |
| 02/14/2014 |
SC 13G/A
| BAKER FELIX reports a 12.3% stake in Diadexus, Inc. |
| 02/14/2014 |
SC 13G/A
| BAKER FELIX reports a 7.4% stake in BioDelivery Sciences International, Inc. |
| 02/10/2014 |
SC 13G/A
| BAKER FELIX reports a 14.3% stake in Derma Sciences, Inc. |
| 11/12/2013 |
SC 13G/A
| BAKER FELIX reports a 6.7% stake in ViroPharma Incorporated |
| 08/12/2013 |
SC 13G/A
| BAKER FELIX reports a 13.2% stake in Diadexus, Inc. |
| 08/12/2013 |
SC 13G/A
| BAKER FELIX reports a 12.9% stake in ViroPharma Incorporated |
| 08/12/2013 |
SC 13G/A
| BAKER FELIX reports a 15.1% stake in Derma Sciences, Inc. |
| 08/12/2013 |
SC 13G/A
| BAKER FELIX reports a 13.4% stake in Pharmacyclics, Inc. |
| 05/10/2013 |
SC 13G/A
| AUXILIUM PHARMACEUTICALS INC reports a 0.6% stake in Auxilium Pharmaceuticals, Inc. |
| 07/23/2012 |
SC 13D/A
| BAKER FELIX reports a 30.6% stake in Xoma Corporation |
| 07/13/2012 |
SC 13D/A
| BAKER FELIX reports a 30.6% stake in Xoma Corporation |
| 04/23/2012 |
SC 13D/A
| BAKER FELIX reports a 30.6% stake in Xoma Corporation |
| 03/28/2012 |
SC 13G/A
| MICROMET, INC. reports a 0% stake in Micromet, Inc. |
| 02/14/2012 |
SC 13G/A
| BAKER FELIX reports a 13.6% stake in Pharmacyclics, Inc. |
| 02/14/2012 |
SC 13G/A
| BAKER FELIX reports a 9.8% stake in Micromet, Inc. |
| 02/14/2012 |
SC 13G/A
| BAKER FELIX reports a 8.2% stake in Tranzyme, Inc. |
| 02/14/2012 |
SC 13G/A
| BAKER FELIX reports a 8.8% stake in BioDelivery Sciences International, Inc. |
| 02/14/2012 |
SC 13G/A
| BAKER FELIX reports a 9.9% stake in Threshold Pharmaceuticals, Inc. |
| 02/14/2012 |
SC 13G
| BAKER FELIX reports a 13.4% stake in Diadexus, Inc. |
| 02/14/2012 |
SC 13G/A
| BAKER FELIX reports a 17.2% stake in VIROPHARMA INCORPORATED |
| 02/14/2012 |
SC 13G/A
| BAKER FELIX reports a 7.5% stake in YM Biosciences, Inc. |
| 02/14/2012 |
SC 13G/A
| BAKER FELIX reports a 13.4% stake in Auxilium Pharmaceuticals, Inc. |
|